NYSE:PBH
Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.'s revenue fell 4.3% in fiscal 2026 to $1.1B while operating margin fell to 28.4%. Free cash flow was $246.4M, 22.6% of revenue, and the diluted share count fell 2.7%.Summary generated from Prestige Consumer Healthcare Inc.'s SEC filings. Latest annual report filed May 14, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$1.1B
Revenue growth−4.3%
Revenue, 5-yr CAGR+2.9%
Gross margin54.7%
Operating margin28.4%
Net margin17.5%
ROIC8.2%
Return on equity10.2%
Debt / equity0.53
Free cash flow$246.4M
FCF margin22.6%
Share count change−2.7%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 1,087 | 1,128 | 1,125 | 1,138 | 1,089 |
| Operating income | 330 | −22 | 342 | 337 | 309 |
| Net income | 205 | −82 | 209 | 215 | 190 |
| Free cash flow | 250 | 222 | 239 | 243 | 246 |
Recent filings
- 8-KDirector or officer change
Aug 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 4Insider transaction report
Aug 5, 2026 - 4Insider transaction report
Aug 5, 2026 - 8-KEntry into a material agreement
Jul 15, 2026 - 8-K/AAmended current report
Jul 9, 2026 - 8-KEntry into a material agreement
Jul 6, 2026